Clinical Trials Browser

INDUSTRY × Colposcopy × Gynecologic × Clear all

NCT07480902 2026-03-18

Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer

Phase NA Recruiting

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Atypical Squamous Cells of the Cervix

NCT07211204 2026-03-03

Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population

Phase NA Withdrawn

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Atypical Squamous Cells of the Cervix

NCT07281599 2026-02-02

EQUIP

Phase NA Recruiting

Genital Diseases, Uterine Cervical Neoplasms, Sexually Transmitted Diseases, Sexually Transmitted Diseases, Viral, Papillomavirus Infections

NCT06815939 2026-01-29

OPTICS

Phase NA Recruiting

10,000 enrolled

GynecologicOther neoplasm

Urogenital Diseases, Genital Diseases, Uterine Cervical Diseases, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Female, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Precancerous Conditions, Urogenital Neoplasms, Uterine Diseases, Uterine Neoplasms

NCT01234480 2023-05-16

Intended Use Study of the BD SurePath Plus™ Pap

5,859 enrolled 4 charts

Uterine Cervical Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Papilloma, Neoplasms, Squamous Cell

NCT02267876 2021-02-08

Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens

Uterine Cervical Neoplasms

NCT01944722 2018-06-12

Clinical Evaluation of the BD Onclarity™ HPV Assay on the BD Viper™ LT System With Cervical Specimens

Phase NA Completed

33,858 enrolled 25 charts

Uterine Cervical Neoplasms

NCT03020121 2018-01-31

Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples

Phase NA Terminated

Uterine Cervical Neoplasms